{"schema_version":"secwatch.filing_event.v1","accession":"0001599298-24-000036","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.759459+00:00","generated_at":"2026-06-05T03:49:01.919037+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Summit Therapeutics to present at Barclays Healthcare Conference on March 12","bullets":["Will present on Tuesday March 12, 2024 at 2:35pm ET.","Presentation will cover development of investigational bispecific antibody ivonescimab.","Presenters include CEO Maky Zanganeh, Chairman Robert Duggan, and other executives.","Live webcast available at www.smmttx.com; archive will be posted."],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-24-000036","json":"https://secwatch.observer/filing/0001599298-24-000036.json","markdown":"https://secwatch.observer/filing/0001599298-24-000036.md","text":"https://secwatch.observer/filing/0001599298-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000036/0001599298-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000036/smmt-20240305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:49:01.919037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}